Fundamental Analysis of MedTech Acquisition Corp - Growth / Value Index
MTAC - Valuation Highlights
Valuation Analysis
Tsr Value Index - Very Poor Score of 19.64
Book Value in last 3 years is trending down
Book value is negative
Valuation Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Price to Earning | 50.39 | 63.98 | -13.93 % | |
| Price to Book | 2.12 | 54.24 | 3621.75 % | -7.73 |
| Price to Sales | 0 | 0 | 0 % | |
| Enterprise Value to EBITDA Multiple | 16.31 | 58.36 | -20.25 % |
MTAC - Profitability Highlights
Profitability Analysis
Strong Return On Capital Employed of 62.20
Tsr Profitability Index - Very Poor Score of 14.77
In the last three years, the company has given poor Net Margin
EPS decline for last four quarters
Profitability Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Return On Equity | 4.58 | 0 | 0 % | 0 |
| Return On Asset | 3.69 | 27.44 | 1350.44 % | -8.13 |
| Net Profit Margin | 0 | 0 | 0 % | 0 |
| Operating Profit Margin | 0 | 0 | 0 % | 0 |
| EBITDA Margin | 0 | 0 | 0 % | 0 |
Highlights
| Market Cap | 83856.92 K |
| Enterprise Value | 86075.56 K |
| Price/Book TTM | 2.12 |
| Outstanding Share | 7394.79 K |
| Float/ Outstanding Share | 7.43% |
| Dividend Yield | 0 % |
Share Holding
Guru Numbers
| Price/Graham No | 11.02 |
| Peter Lynch Ratio | 0.321 |
| Piotroski F Score | 4.00 |
| Altman Z Score | 3.64 |
| Sloan Ratio | -11.14 |
MTAC - Growth Highlights
Growth Analysis
Quarterly sales in last 5 years is trending up
Tsr Growth Index - Poor Score of 22.90
Quarterly sales in last 5 Quarter is trending down
Growth Key Fields
| Field | TTM | YoY Growth | QoQ Growth |
|---|---|---|---|
| Revenue | NA | % | % |
| Gross Profit | NA | % | % |
| EBITDA | 5276.60 K | 26.47 % | 239.68 % |
| Net Profit | 4095.94 K | 16.19 % | 122.06 % |
| EPS | 0.225 | 16.19 % | NA |
MTAC - Stability Highlights
Stability Analysis
Tsr Stability Index - Very Poor Score of 17.86
Company is unable to generate enough free cash to support the business.
Interest Coverage of 0
Stability Key Ratios
| Ratio | Latest FY | Yoy Change | MRQ |
|---|---|---|---|
| Debt to Equity Ratio | -0.179 | -8092.50 % | -0.512 |
| Cash Ratio | 0.061 | -99.53 % | |
| Quick Ratio | 0 | 0 % | 0.0268 |
| Shareholders Equity | -65.72 | -168.11 % | |
| Debt to EBITDA | 0.388 | 244.81 % |
Historical Valuation Ratios of MedTech Acquisition Corp
Historical Valuation Ratios
Loading ...
Historical Profitability Ratios of MedTech Acquisition Corp
Historical Profitability Ratios
Loading ...
Historical Efficiency Ratios of MedTech Acquisition Corp
Historical Efficiency Ratios
Loading ...
Historical Solvency Ratios of MedTech Acquisition Corp
Historical Solvency Ratios
Loading ...
Note : All Data Generated at the End of Trading Hours (EOD Data)